Anzeige
Mehr »
Login
Mittwoch, 28.10.2020 Börsentäglich über 12.000 News von 649 internationalen Medien
Unglaublicher News-Flow!!! Diese Firma liefert einfach gewaltig ab!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A0NBNG ISIN: US0231112063 Ticker-Symbol: EH3A 
Tradegate
28.10.20
11:39 Uhr
4,030 Euro
-0,070
-1,71 %
Branche
Pharma
Aktienmarkt
NASDAQ Biotech
1-Jahres-Chart
AMARIN CORPORATION PLC ADR Chart 1 Jahr
5-Tage-Chart
AMARIN CORPORATION PLC ADR 5-Tage-Chart
RealtimeGeldBriefZeit
3,9404,00018:20
3,9404,00018:16

Aktuelle News zur AMARIN Aktie

  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
AMARIN Aktie jetzt für 0€ handeln
MoAmarin's Vascepa Shows Reduced Cardiovascular Events in Kidney Patients in Latest Study11
MoAmarin Corporation plc: VASCEPA (Icosapent Ethyl) Found to Significantly Reduce Cardiovascular Events in Patients with Compromised Renal Function at Baseline ...9
FrAmarin Corporation plc: U.S. Veterans with Decreased Renal Function Shown to Be at Higher Risk for Adverse Cardiovascular Events if They Have Moderately ...15
16.10.The Daily Biotech Pulse: Amarin Vascepa Data, Galapagos Osteoarthritis Drug Update, 4 IPOs43
16.10.Pre-market Movers In Healthcare Sector: RWLK, ETTX, AMRN, CEMI...275SUNNYVALE (dpa-AFX) - What's moving these stocks in the pre-market hours today?In the Green1. ReWalk Robotics Ltd. (RWLK), a manufacturer of robotic medical devices for individuals with lower...
► Artikel lesen
15.10.AMRN, CHWY, RLGY and KC among after-hours movers20
15.10.Amarin gains after Vascepa found to significantly reduce ischemic events in PCI patients16
15.10.Amarin Corporation plc: VASCEPA (Icosapent Ethyl) Found to Significantly Reduce Ischemic Events in Patients with Prior Percutaneous Coronary Intervention ...15
06.10.Unusual Options Activity Insight: Amarin Corp50
05.10.Amarin Corporation plc: Latest Research Evaluating VASCEPA (Icosapent Ethyl) Mechanisms of Action Presented at European Atherosclerosis Society (EAS) ...69
16.09.Amarin (AMRN) Investor Presentation - Slideshow73
16.09.Amarin Corporation plc (AMRN) CEO John Thero Presents at Cantor Virtual Global Healthcare Conference (Transcript)27
15.09.Hedge Funds Are Dumping Amarin Corporation plc (AMRN)59
09.09.Amarin: 'The Future Ain't What It Used To Be'79
07.09.Amarin Is A Good Contrarian Pick To Consider After Post-Appeal Sell-Off75
04.09.Amarin Loses Patent Appeal in Vascepa Lawsuit, Stock Dips63
03.09.AMARIN CORP PLC - 8-K, Current Report35
03.09.Appeals Court Rules Against Amarin in Vascepa Patent Dispute40
03.09.Amarin loses patent appeal and their brief grip on a cardiovascular, fish oil empire30
03.09.HLS Therapeutics Comments on U.S. Court of Appeals Decision in Amarin Patent Litigation13
Seite:  Weiter >>
114 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,12